TOP STORIES

• REGULATORY Generics from 5 Companies Enough When Major Products Lose Patent Protection: Top Bureaucrat
  September 13, 2016

• BUSINESS Nippon Shinyaku on Track to Achieve Targets in Midterm Plan with Sales of Selexipag Above Expectations: President
  September 12, 2016

• REGULATORY MHLW Panel Backs BI’s Triple Combo After 3rd Try
  September 9, 2016

• BUSINESS Biogen Japan’s Hemophilia Spinoff to Be Up and Running in Early 2017
  September 8, 2016

• ORGANIZATION Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
  September 7, 2016

• REGULATORY 6 National Centers Log Generic Use Rate of Average 73.8% in FY2015
  September 6, 2016

• BUSINESS Oncolys to Evaluate Oncolytic Virus in Combination with Immune Checkpoint Inhibitors; Interim Results Expected in 2017
  September 5, 2016

• BUSINESS Otsuka, RIKEN Open Collaborative Research Center to Promote Regenerative Medicine
  September 2, 2016

• BUSINESS Harvoni Outstrips Plavix to Top FY2015 Japan Sales Ranking: Jiho Tally
  September 1, 2016

• REGULATORY Lilly Drops Listing of Taltz amid Pricing Fuss, Wants to Deliver Drug without Restrictions
  August 31, 2016

• REGULATORY MHLW Panel to Discuss Keytruda on Sept. 9, Listing Expected as Early as November
  August 30, 2016

• BUSINESS Sizzling DOAC Market - 4: Companies Aim to Differentiate Their Products through Quality of Information
  August 29, 2016

• BUSINESS Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
  August 26, 2016

• REGULATORY Chuikyo Subcommittee Effectively Kicks Off Debates on FY2018 Reform, with Focus on Pricy Meds
  August 25, 2016

• REGULATORY After Taltz Given High Price, MHLW to Push Use of Other Psoriasis Drugs; Revision to Foreign Price Adjustment Eyed
  August 25, 2016

• REGULATORY Chuikyo OKs Praluent, 8 Other APIs for Listing on Aug. 31
  August 24, 2016

• BUSINESS Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
  August 24, 2016

• REGULATORY MHLW to Seek Funding to Promote and Support Healthcare Startups in FY2017 Budget Request
  August 23, 2016

• REGULATORY MHLW Set to Defend “High-Level Investment” Credits for Key R&D Tax Break System in FY2017 Reform
  August 22, 2016

• BUSINESS Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
  August 22, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• …
• Next ›
• 最終 »